0001209191-23-045479.txt : 20230811
0001209191-23-045479.hdr.sgml : 20230811
20230811172857
ACCESSION NUMBER: 0001209191-23-045479
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230809
FILED AS OF DATE: 20230811
DATE AS OF CHANGE: 20230811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Prout Samantha
CENTRAL INDEX KEY: 0001743122
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 231165319
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
FORMER NAME:
FORMER CONFORMED NAME: Prout Samantha Whiteman
DATE OF NAME CHANGE: 20180607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (215) 921-7600
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
FORMER COMPANY:
FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC
DATE OF NAME CHANGE: 20020729
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-09
0
0001178879
AMICUS THERAPEUTICS, INC.
FOLD
0001743122
Prout Samantha
C/O AMICUS THERAPEUTICS, INC.
3675 MARKET STREET
PHILADELPHIA
PA
19104
0
1
0
0
Chief Accounting Officer
1
Common Stock
2023-08-09
4
M
0
2376
10.04
A
139379
D
Common Stock
2023-08-09
4
M
0
5040
9.55
A
144419
D
Common Stock
2023-08-09
4
M
0
10592
10.03
A
155011
D
Common Stock
2023-08-09
4
M
0
18901
12.11
A
173912
D
Common Stock
2023-08-09
4
S
0
36909
14.0056
D
137003
D
Stock Options (right to buy)
10.04
2023-08-09
4
M
0
2376
0.00
D
2029-01-02
Common Stock
2376
0
D
Stock Options (right to buy)
9.55
2023-08-09
4
M
0
5040
0.00
D
2030-01-02
Common Stock
5040
2526
D
Stock Options (right to buy)
10.03
2023-08-09
4
M
0
10592
0.00
D
2030-04-15
Common Stock
10592
3176
D
Stock Options (right to buy)
12.11
2023-08-09
4
M
0
18901
0.00
D
2032-01-14
Common Stock
18901
37810
D
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.00 to $14.10 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
All of these options were fully vested and exercisable as of the transaction date.
As of August 9, 2023, 5,985 options were fully vested and exercisable and 1,581 remained unvested from this individual 2020 grant.
As of August 9, 2023, 11,164 options were fully vested and exercisable and 2,604 remained unvested from this individual 2020 grant.
As of August 9, 2023, 22,444 options were fully vested and exercisable and 34,267 remained unvested from this individual 2022 grant.
All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2023.
/s/ Christian Formica, Attorney-in-Fact
2023-08-11